Atossa Therapeutics Inc (ATOS) Stock Price, Quote, News & History

ATOSNASDAQ
$2.48
-0.03-1.2%
At close: Sep 14, 5:00 PM EST
$2.41
-0.07-2.82%
After Hours: Sep 11, 7:03 PM EST

Atossa Therapeutics (ATOS) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-35.77M
Investing Cash Flow (TTM)
-14.00K
Financing Cash Flow (TTM)
4.02M
Free Cash Flow (TTM)
-35.78M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-31.76M

Analyst Trends and Forecast

1
Mar
1
Apr
1
Jul
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$1.15M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.93
Earnings Yield % (TTM)
-173.60%
Earnings Yield % (FWD)
-101.00%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.69

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$26.09M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$2.53
Close
$2.48
Volume / Avg.
35.04K / 153.43K
Day Range
$2.45 - $2.56
52 Wk Range
1.70 - 19.35
Market Cap
$24.05M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
49
Short Interest
7.58%
Days to Cover
12.5

About

Sector
Health Care
Industry
Biotechnology
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Atossa Therapeutics (ATOS) stock?

A

You can purchase shares of Atossa Therapeutics (NASDAQ:ATOS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Atossa Therapeutics (ATOS) competitors?

Q

What is the forecast, or price target, for Atossa Therapeutics (ATOS) stock?

A

Atossa Therapeutics has a consensus price target of $20.25.

Q

What is the current price for Atossa Therapeutics (ATOS)?

A

The stock price for Atossa Therapeutics (NASDAQ: ATOS) is $2.41 last updated September 11, 2026 at 7:03 PM EDT.

Q

Does Atossa Therapeutics (ATOS) pay a dividend?

A

There are no upcoming dividends for Atossa Therapeutics.

Q

When is Atossa Therapeutics (NASDAQ:ATOS) reporting earnings?

A

Atossa Therapeutics does not have any upcoming earnings scheduled.

Q

Is Atossa Therapeutics (ATOS) going to split?

A

There is no upcoming split for Atossa Therapeutics.

Q

What sector and industry does Atossa Therapeutics (ATOS) operate in?

A

Atossa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.